Revised: 15 January 2026
Information for Healthcare Professionals
This section provides information useful to healthcare professionals.
Medsafe Advice
| Date | Type | Title |
|---|---|---|
| 5/3/2026 | Publications | Prescriber Update Vol. 47. No. 1 - March 2026 |
| 2/3/2026 | Consultation | Outcome of the consultation on the proposal for the package labelling of topical corticosteroids to state their potency |
| 20/2/2026 | Consultation | Verification Pathway for New Medicine Applications |
| 16/2/2026 | Medicines | Policy Statements - Declaring excipient(s) with known effect in data sheets |
| 26/1/2026 | Monitoring Communication |  Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide, semaglutide, tirzepatide) and acute persistent visual loss |
| 15/1/2026 | Notices | Updated Clinical Trial Guidelines |
| 15/1/2026 | Consultation | Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials |
| 15/1/2026 | Consultation | Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications |
If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.
